Amani Therapeutics
New York, US · Founded 2025 · Delaware corporation · 1 known investors
Find your way into Amani Therapeutics
Sign up to see every warm intro you have to Amani Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amani Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AL
Alice LeeNamed on SEC filing
RS
Robert SwobodaNamed on SEC filing
LC
Lauren CujeNamed on SEC filing
PF
Peter FongNamed on SEC filing
CW
Connor WilliamsNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$66.1M disclosed across 2 rounds · 2025–2026
▶$35MraisedOct 2026 · 5 investors · Other Health CareRule 506(b)
▶$35MraisedOct 2026 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alice LeeExecutive Officer
- -- RTW Holdings VI, LLCPromoter
- Robert SwobodaExecutive Officer
- Lauren CujeDirector
- Peter FongDirector
- Connor WilliamsDirector
- Offering amount
- $60M
- Amount sold
- $35M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$31.1MraisedDec 2025 · 2 investors · Other Health CareRule 506(b)
▶$31.1MraisedDec 2025 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alice LeeExecutive Officer, Director
- -- RTW Holdings VI, LLCPromoter
- Offering amount
- $31.1M
- Amount sold
- $31.1M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Amani Therapeutics's investors?
- Amani Therapeutics's investors include RTW Investments L.P..
- How much funding has Amani Therapeutics raised?
- Amani Therapeutics has disclosed $66.1M raised across 2 rounds.
- Where is Amani Therapeutics headquartered?
- Amani Therapeutics is headquartered in New York, US.
